Indications and uses
Temporarily relieves these symptoms of the common cold, hay fever, or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
Temporarily relieves these symptoms of the common cold, hay fever, or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
adults and children 12 years and older: 1 tablet every 12 hours; not more than 2 tablets in 24 hours children under 12 years: ask a doctor
Clemastine fumarate 1.34 mg (equivalent to 1 mg clemastine)
Antihistamine
In case of overdose, get medical help or contact a Poison Control Center right away.
Temporarily relieves these symptoms of the common cold, hay fever, or other upper respiratory allergies:
taking sedatives or tranquilizers.
aska health professional before use.
adults and children 12 years and older: | 1 tablet every 12 hours; not more than 2 tablets in 24 hours |
children under 12 years: | ask a doctor |
Hydroxypropyl methylcellulose, lactose (monohydrate), magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and starch (corn).
1-800-525-8747
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f7e17947-a18d-ce47-e13b-48f8b11c0c6f | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68151-2456-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4735-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68151-2456-0 | Clemastine Fumarate | 1 in 1 PACKAGE | TABLET | 1 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68151-2456 | CLEMASTINE FUMARATE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | Legacy NDC, 1 package rows | 20140708_74f3a9fb-c35e-4720-9538-0a0afe0a773d.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-1358-01 | EA - Each | 0781-1358 | 97e7426a-b454-4762-935c-bf604f5dea08 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CLEMASTINE FUMARATE | ACTIVE INGREDIENT | 19259EGQ3D | 2 | |
| CLEMASTINE | ACTIVE MOIETY | 95QN29S1ID | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68151-2456 | 68151-2456-0 |
| 0781-1358 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CLEMASTINE FUMARATE | 19259EGQ3D | ACTIB |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CAPSULE / ORAL | 3990 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | SUSPENSION / ORAL | 156 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, EXTENDED RELEASE / ORAL | 2575 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 21 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 750 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 150 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, ORALLY DISINTEGRATING / ORAL | 366 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FOR SUSPENSION / ORAL | 2794 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / SUBLINGUAL | 505 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, COATED / ORAL | 1301 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER, FOR SUSPENSION / ORAL | NA | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 36 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | CAPSULE, EXTENDED RELEASE / ORAL | 105 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | PASTILLE / ORAL | NA | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | TABLET, EXTENDED RELEASE / ORAL | 231 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | CAPSULE / ORAL | 400 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION / ORAL | 900 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | TABLET, DELAYED RELEASE / ORAL | 140 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / BUCCAL | 16.6 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INSERT / VAGINAL | 2282 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | GRANULE, FOR SUSPENSION / ORAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | GRANULE, FOR SUSPENSION / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | TABLET / ORAL | 570 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | INSERT / VAGINAL | 147 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| HYPROMELLOSE 2910 (3 MPA.S) | HYPROMELLOSE 2910 (3 MPA.S) | 0VUT3PMY82 | TABLET, ORALLY DISINTEGRATING / ORAL | 52 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE / ORAL | 5785 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / SUBLINGUAL | 409 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 47.5 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 214 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A073458-001 | CLEMASTINE FUMARATE | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A073458-001 | CLEMASTINE FUMARATE | 1.34MG | TABLET / ORAL | 1993-10-31 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0381b7d6-b261-4c91-9399-bb31be8aa41d | 74f3a9fb-c35e-4720-9538-0a0afe0a773d | 2012-04-09 | Warnings | 0381b7d6-b261-4c91-9399-bb31be8aa41d 74f3a9fb-c35e-4720-9538-0a0afe0a773d |
Adverse event summaries are temporarily unavailable. Other product information remains available.